COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily

被引：0

作者：

Ziemssen, T. ^{[1
]}

Bajenaru, O. ^{[2
]}

Carra, A. ^{[3
]}

de Klippel, N. ^{[4
]}

de Sa, J. ^{[5
]}

Edland, A. ^{[6
]}

Frederiksen, J. ^{[7
]}

Heinzlef, O. ^{[8
]}

Karageorgiou, K. ^{[9
]}

Landtblom, A. M. ^{[10
]}

Macias Islas, M. ^{[11
]}

Tubridy, N. ^{[12
]}

Gilgun-Sherki, Y. ^{[13
]}

机构：

[1] Klinikum Carl Gustav Carus, Dresden, Germany

[2] Carol Davila Univ Med & Pharm, Bucharest, Romania

[3] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina

[4] Virga Jessaziekenhuis, Hasselt, Belgium

[5] Hosp Santa Maria, Lisbon, Portugal

[6] Cent Hosp Buskerud, Drammen, Norway

[7] Univ Copenhagen, Glostrup, Denmark

[8] Tenon Hosp, Paris, France

[9] G Gennimatas Gen Hosp Athens, Athens, Greece

[10] Linkoping Univ, Linkoping, Sweden

[11] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico

[12] Univ Coll Dublin, Dublin 2, Ireland

[13] Teva Pharmaceut Ind, Petah Tiqwa, Israel

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：444 / 445

页数：2